IL212118A - Emulsion vaccine - Google Patents

Emulsion vaccine

Info

Publication number
IL212118A
IL212118A IL212118A IL21211811A IL212118A IL 212118 A IL212118 A IL 212118A IL 212118 A IL212118 A IL 212118A IL 21211811 A IL21211811 A IL 21211811A IL 212118 A IL212118 A IL 212118A
Authority
IL
Israel
Prior art keywords
vaccine formulation
anthrax vaccine
anthrax
formulation
vaccine
Prior art date
Application number
IL212118A
Other languages
English (en)
Hebrew (he)
Other versions
IL212118A0 (en
Original Assignee
Pharmathene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmathene Inc filed Critical Pharmathene Inc
Publication of IL212118A0 publication Critical patent/IL212118A0/en
Publication of IL212118A publication Critical patent/IL212118A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/07—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL212118A 2008-10-02 2011-04-04 Emulsion vaccine IL212118A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19496708P 2008-10-02 2008-10-02
PCT/GB2009/051293 WO2010038076A1 (en) 2008-10-02 2009-10-02 Anthrax vaccine formulation and uses thereof

Publications (2)

Publication Number Publication Date
IL212118A0 IL212118A0 (en) 2011-07-31
IL212118A true IL212118A (en) 2017-03-30

Family

ID=41292568

Family Applications (1)

Application Number Title Priority Date Filing Date
IL212118A IL212118A (en) 2008-10-02 2011-04-04 Emulsion vaccine

Country Status (7)

Country Link
US (1) US9616117B2 (enExample)
EP (1) EP2344188B1 (enExample)
JP (1) JP5701760B2 (enExample)
AU (1) AU2009299615B2 (enExample)
CA (1) CA2738621C (enExample)
IL (1) IL212118A (enExample)
WO (1) WO2010038076A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2738621C (en) 2008-10-02 2017-01-31 Pharmathene Inc. Anthrax vaccine formulation and uses thereof
WO2014134187A1 (en) * 2013-02-26 2014-09-04 The Regents Of The University Of California Compositions and methods for the treatment of cancer

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK140815B (da) 1975-06-10 1979-11-19 Weeke Bengt Fremgangsmåde til påvisning eller bestemmelse af antistoffer i legemsvæsker ved hjælp af kendte antigener eller til bestemmelse af antigener ved hjælp af kendte antistoffer fra legemsvæsker samt et middel til anvendelse ved udøvelse af fremgangsmåden.
DE2632478A1 (de) 1975-07-23 1977-02-24 Coulter Electronics Verfahren zur erfassung und trennung von antigenen und antikoerperchen im blut und in anderen proben
US4486530A (en) 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
JPH0779694B2 (ja) 1985-07-09 1995-08-30 カドラント バイオリソ−シズ リミテツド 蛋白質および同類品の保護
US5690942A (en) 1995-06-02 1997-11-25 American Home Products Corporation Adjuvants for viral vaccines
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
GB9618107D0 (en) 1996-08-30 1996-10-09 Secr Defence Vaccine production
US20020120228A1 (en) 2000-06-08 2002-08-29 Yuh-Fun Maa Powder compositions
CA2412197A1 (en) 2000-06-08 2001-12-13 Powderject Vaccines, Inc. Powder compositions
GB0016702D0 (en) 2000-07-08 2000-08-23 Secr Defence Brit Expression system
WO2002100340A2 (en) 2001-06-08 2002-12-19 Avant Immunotherapeutics, Inc. Improved vaccination against anthrax
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
GB0126266D0 (en) 2001-11-01 2002-01-02 Microbiological Res Authority Anthrax antigenic compositions
UA80809C2 (en) 2001-11-05 2007-11-12 Process for preparation of protective antigen protein of anthracis with e.coli
MXPA04005538A (es) 2001-12-05 2005-06-08 Bhatnagar Rakesh Procedimiento para la preparacion de una vacuna no toxica contra el antrax.
WO2005123131A2 (en) 2004-06-14 2005-12-29 Medimmune Vaccines, Inc. High pressure spray-dry of bioactive materials
WO2004073735A1 (en) 2003-02-13 2004-09-02 Becton, Dickinson And Company Improved anthrax vaccines and delivery methods
US7355027B2 (en) 2004-06-16 2008-04-08 Dynport Vaccine Company Llc Bacillus anthracis protective antigen
KR20070057954A (ko) 2004-09-28 2007-06-07 알자 코포레이션 알룸-애주번트가 있는 면역 활성제의 안정화
GB0525213D0 (en) 2005-12-12 2006-01-18 Secr Defence Vaccine
WO2008048344A2 (en) 2006-02-13 2008-04-24 Fraunhofer Usa, Inc. Bacillus anthracis antigens, vaccine compositions, and related methods
GB0607462D0 (en) 2006-04-13 2006-05-24 Avecia Ltd Assay
WO2008079464A2 (en) 2006-09-08 2008-07-03 Becton, Dickinson And Company Stable powder formulations of alum-adsorbed vaccines
EP1972347A1 (en) 2007-03-19 2008-09-24 Becton, Dickinson and Company, Wagner, Jaconda Stable vaccine powder formulations
WO2008152654A1 (en) 2007-06-11 2008-12-18 Panacea Biotec Limited Anthrax fusion proteins, compositions and uses thereof
GB0801122D0 (en) * 2008-01-22 2008-02-27 Avecia Biolog Ltd Vaccine composition
CA2738621C (en) 2008-10-02 2017-01-31 Pharmathene Inc. Anthrax vaccine formulation and uses thereof
CA2750321A1 (en) 2009-01-22 2010-07-29 Pharmathene, Inc. Stable vaccine compositions and methods of use

Also Published As

Publication number Publication date
JP5701760B2 (ja) 2015-04-15
US9616117B2 (en) 2017-04-11
WO2010038076A1 (en) 2010-04-08
IL212118A0 (en) 2011-07-31
CA2738621C (en) 2017-01-31
US20110236425A1 (en) 2011-09-29
AU2009299615B2 (en) 2015-07-16
JP2012504589A (ja) 2012-02-23
EP2344188B1 (en) 2017-02-15
CA2738621A1 (en) 2010-04-08
EP2344188A1 (en) 2011-07-20
AU2009299615A1 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
GB0810305D0 (en) Influenza vaccination
ZA200808489B (en) Nicotine-carrier vaccine formulation
ZA201101481B (en) Vaccine
IL212200A0 (en) Vaccine composition for use against influenza
IL208651A0 (en) Vaccine
GB0822001D0 (en) Vaccine
ZA201102446B (en) Oral formulation
GB0810710D0 (en) Vaccine
ZA201007402B (en) Vaccine
GB0822633D0 (en) Formulation
PL2207567T3 (pl) Preparat immunogenny
ZA201100962B (en) Influenza vaccines
GB0816447D0 (en) Vaccine
GB0816284D0 (en) Vaccine
ZA201004772B (en) Novel formulation
EP2252326A4 (en) VACCINE COMPOSITIONS
EP2097103A4 (en) VACCINE FORMULATIONS AGAINST INFLUENZA
GB0801326D0 (en) Vaccines
GB0814376D0 (en) Formulation
IL212118A0 (en) Anthrax vaccine formulation and uses thereof
GB0801122D0 (en) Vaccine composition
GB0912666D0 (en) Vaccine formulation
GB0610095D0 (en) Vaccine formulation
GB0806445D0 (en) Formulation
GB0817663D0 (en) Formulation

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed